The Raltegravir and Ribavirin Pharmacokinetics (PK) Study

NCT00982553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ribavirin
DRUG: Raltegravir

Sponsor

Imperial College London